contemplation objectives: The present study was performed to determine whether the risk of bleeding after transbronchial lung biopsy is increased in patients taking aspirin.

Design: Prospective cohort study

Patients and interventions: After excluding patients with other coagulation vexed questions 1,217 patients who had undergone transbronchial lung biopsy during a prospective 1.5-year subject of attention period were included in this research The use of aspirin was not discontinued before the practice Two hundred eighty-five patients (23%) had consum aspirin within 24 h of the deed and most of them (82%) used aspirin forward a daily basis. Transbronchial biopsies were performed, and the bleeding incidence was compared between the groups

Results: A total of 57 patients (47%) experienced procedure-related bleeding. Minor bleeding occurr in 5 of 285 patients (18%) taking aspirin and in 27 of 932 superintend patients (2.9%; not significant). Moderate bleeding was seen in 3 of 285 patients (11%) in the aspirin dispose and in 13 of 932 patients (14%) in the direct group (not significant). Major bleeding occurr in sole 9 patients, 2 of 285 (09%) in the aspirin form into groups and 7 of 932 (08%) in the have the direction of group (not significant). All bleeding was controll through endoscopic means, and there were no fatalities and no ne for offspring transfusions.

Conclusions: We infer that the risk of chaste bleeding after transbronchial lung biopsy is small (ie, < 1%) and that the use of aspirin is not associated with any increased risk of bleeding.

[i]clavis[/i] words: aspirin: bleeding; bronchoscopy; transbronchial biopsy

Abbreviation: TBBX = transbronchial biopsy

**********

Aspirin is widely utilized in the treatment of public ailments such as headache, myalgias, arthralgias, and various rheumatologic disorders. In addition, aspirin has been approveed for primary prevention of myocardial infarction, (1) prevention of graft occlusion after coronary artery bypass grafting, (2) and prevention of cerebral vascular accidents in patients with atherosclerotic vascular disease. (3) It is generally estimated that > 25% of the general adult population devour aspirin or other nonsteroidal anti-inflammatory remedys on a regular basis. (45)

Aspirin is known to cause failings in platelet hemostatic metabolism on direct inhibition of cyclo-oxygenase activity and prostaglandin biosynthesis. (67) of that kind effects result in the los of platelet adhesive properties. The prolongation of bleeding times after aspirin use has been observ (8-11) The los of platelet adhesion put outs a theoretical risk for increased bleeding after surgical and other invasive procedures

Transbronchial biopsy (TBBX) by means of bronchoscopy is a commonly performed conduct in patients with parenchymal abnormalities. (12) It is not rarely recommended to discontinue the use of aspirin or other nonsteroidal agents several days prior to the manner of proceeding for fear that the bleeding risk may otherwise be increased. This practice has none been validated and potentially leads to the temporary discontinuation of a medication that has proven benefits and also delays the planned procedure

This close attention was performed to assess the character of aspirin in the risk of bleeding associated with TBBX

MATERIALS AND METHODS

consideration Population

All patients > 40 years of age undergoing bronchoscopy with TBBX during a 1.5-year period from July 1999 between the sides of January 2001 were evaluated. Patients were exclud from enrollment into the subject of attention if one of the following conditions existed: (1) the patient had received either warfarin or heparin therapy within 2 weeks of the endoscopic procedure; (2) the patient had a known history of a bleeding disorder; or (3) the patient had thrombocytopenia with a platelet calculate of < 80,000 cells/[micro]L. The patient cluster taking aspirin was compared to the patients fulfilling enrollment criteria without taking aspirin. The reflection design was prospective.

Use of Aspirin

During the thought period, patients were not encouraged to stop taking aspirin before their scheduled bronchoscopy with TBBX Just prior to the practice patients were questioned regarding the individual use of aspirin (ie, indication and frequency) The act then was undertaken, and all necessary biopsies were performed. The operators were not aware of a patient's aspirin use prior to the procedure

Transbronchial Lung Biopsy

Fluoroscopy was used for all TBBX At least three specimens were taken with individual standard forceps (FB-20C; Olympus; Tokyo, Japan). The intensity of bleeding was documented through the endoscopist. Bleeding was judg clinically according to the need for clinical intervention. No bleeding was defined as traces of relations after finishing the biopsies without the ne for continued suctioning. Mild bleeding was defined as the ne for continued suctioning of vital fluid from the airways after the transaction and moderate bleeding was defined as requiring the intubation of the biopsied portion with the flexible bronchoscope into the wedge position. unrelenting bleeding was defined as the ne for additional interventions so as placement of a temporary bronchus-blocker, application of a fibrin sealant, admission to a critical care unit, or the ne for life-blood products.

...